Region: Latin America & Caribbean

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

The challenges that innovators face when enforcing and defending their rights depend on how developed the regulatory framework is, and the courts’ approach to patent cases. Against this backdrop, the biosimilar industry is tackling regulatory uncertainties and Mexico's 2024 elections could prove pivotal when it comes to developing a strategy to combat these issues. 

24 June 2024

Featured in The Guide to Life Sciences: Key issues for senior life sciences executives 2024

Brazil is a strategic market for many local and foreign pharmaceutical companies due to its protective legislation with regard to access to healthcare. However, its pharma ecosystem is complex and requires a comprehensive understanding of the legal framework that governs IP protection. 

24 June 2024

Huawei and pharma giant Hengrui Pharmaceuticals are among the top patent filers in Latin America’s hottest IP jurisdiction

30 May 2024

IAM sat down with unit head Benjamin Wu to discuss his team’s work, licensing ambitions and the importance of Brazil

15 May 2024

It is also unclear whether thousands of pending challenges will be affected by the process change

26 April 2024

The decision hands an agribusiness asset case back to the trial court with potentially heavy financial ramifications for the IP owner and parent company Bayer

17 April 2024

Featured in SEP/FRAND Hub 2023/2024

DivX, Ericsson, Dolby and Nokia are among the successful patent holders that have won preliminary injunctions in 2023. Brazil’s critical position in the tech market, as well as the willingness of courts to grant injunctions are cementing the country’s status as a key litigation venue.

14 March 2024

In the week we celebrate International Women’s Day, we look at the progress being made in Latin America’s largest economy

06 March 2024

Rio court more likely to grant sales prohibitions than São Paolo counterpart, Clarivate data suggests

21 February 2024

The recently settled battles offer several lessons for patent strategists

20 February 2024